Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What Each Is
Fisetin
Dietary SupplementFisetin is a flavonoid from strawberries studied for senolytic activity. Emerged as a lead compound in 2018. Early-stage human evidence. Very poor bioavailability.
Resveratrol
Dietary SupplementResveratrol (3,5,4′-trihydroxystilbene) is a stilbenoid found in red grape skin, red wine, berries, and peanuts. Popularized by the 'French Paradox' hypothesis. Studied for SIRT1 activation, AMPK, anti-inflammatory effects, and proposed caloric restriction mimicry. Longer research history but significant reproducibility challenges in human trials.
Evidence Type Comparison
Understanding the difference in evidence quality between these options.
| Aspect | Fisetin | Resveratrol |
|---|---|---|
| FDA Status | Not FDA-approved for any condition | Not FDA-approved for any condition |
| Primary Mechanism | Senolytic (BCL-xL); NF-κB, Nrf2, mTOR/AMPK | SIRT1 activation; AMPK; anti-inflammatory; caloric restriction mimicry |
| Human Evidence Stage | Early-stage (safety/tolerability) | Hundreds of trials, mostly inconsistent/disappointing |
| Oral Bioavailability | <10% | Poor (rapid metabolism to glucuronides/sulfates) |
| Dosing Approach | Intermittent high-dose (20 mg/kg, 2 days/month) | Daily 150–1500 mg |
| Safety Data Maturity | Limited | More extensive (multiple trials) |
Mechanism Hypotheses (Conceptual)
Note: Mechanism hypotheses describe how compounds are thought to work based on laboratory research. This does not confirm clinical benefit or efficacy in humans.
Fisetin
Senolytic activity (BCL-xL inhibition), NF-κB anti-inflammatory effects, Nrf2 antioxidant activation, mTOR/AMPK modulation. Primary research interest is senescent cell clearance.
Resveratrol
SIRT1 activation (sirtuin pathway), AMPK activation, anti-inflammatory effects, proposed caloric restriction mimicry. Originally popularized by the 'French Paradox' hypothesis. Has a longer research history but has faced significant reproducibility challenges.
Critical difference: Resveratrol's clinical trajectory offers a cautionary parallel for fisetin: despite enormous preclinical promise and consumer enthusiasm, human trials with resveratrol have produced mostly disappointing or inconsistent results, particularly for cardiovascular and longevity endpoints.
Safety & Tolerability Patterns
Fisetin
Limited human safety data. 2-day intermittent dosing protocol. Mild GI side effects. No comprehensive drug interaction data.
Resveratrol
More extensive human safety data from multiple clinical trials. Generally well-tolerated at 150–1500 mg/day. Some evidence for GI side effects at higher doses. Known CYP enzyme interactions. Has been studied for longer periods than fisetin.
Key difference: Resveratrol has more extensive human safety data, though its clinical efficacy results have been disappointing.
Drug Interaction Considerations
Both fisetin and resveratrol may interact with CYP3A4 drug-metabolizing enzymes. Resveratrol is better characterized in this regard.
Always discuss any supplements with your pharmacist, especially if you take prescription medications.
Decision Factors to Discuss Clinically
These factors should be discussed with your healthcare provider—not decided based on online information alone:
- •Current medications and potential interactions
- •Other health conditions (comorbidities)
- •Symptom severity and impact on quality of life
- •Your goals and preferences for treatment approach
- •How you'll objectively track symptom changes
Questions to Bring to Your Appointment
Discussing supplements with your healthcare provider
Between these supplements, which has the most evidence for my goals?
Comparing options based on published clinical evidence
Could combining supplements increase side effect risk?
Understanding multi-ingredient formulas and interactions
How do I choose a quality supplement product?
Third-party testing, standardization, reputable brands
What's a reasonable trial period before deciding if a supplement works?
Timeline for evaluation
At what point should I consider prescription options instead?
Knowing when supplements aren't enough
Tip: Write down these questions before your appointment. Bring a list of all current medications and supplements you take, including dosages. Consider asking about objective symptom tracking to measure changes over time.
Quick Answers
Is fisetin better than resveratrol?
For senolytic activity, fisetin showed stronger potency in the 2018 screening. But resveratrol has far more human clinical data (though results are inconsistent). Neither is proven 'better' for any health outcome.
What does resveratrol do?
Resveratrol activates SIRT1 (sirtuin pathway) and AMPK, with anti-inflammatory and proposed caloric-restriction-mimicking effects. It was popularized by the 'French Paradox' hypothesis.
Has resveratrol failed in human trials?
Resveratrol's human trials have produced mostly disappointing or inconsistent results, particularly for cardiovascular and longevity endpoints. It shows modest benefits for glucose metabolism in some trials.
Do both have bioavailability problems?
Yes. Both have poor oral bioavailability and face similar challenges translating cell culture findings to clinical efficacy. Resveratrol is rapidly metabolized to glucuronides and sulfates.
Which is a better senolytic?
Fisetin showed substantially stronger senolytic activity than resveratrol in the 2018 Mayo Clinic flavonoid screening.
Is the French Paradox relevant to fisetin?
No. The French Paradox hypothesis (red wine resveratrol explains lower cardiovascular mortality) has been largely debunked. Fisetin is unrelated to this hypothesis.
Can I take both fisetin and resveratrol?
No study has examined the combination. Both have poor bioavailability and potential CYP interactions. Consult a healthcare provider before combining.
Which has more clinical data?
Resveratrol has hundreds of published human clinical trials vs fewer than 15 for fisetin, but many resveratrol trials had methodological limitations.
Is resveratrol still worth taking?
Resveratrol's clinical results have been disappointing. Some modest metabolic benefits are reported. Whether it's 'worth taking' is a personal decision to discuss with a healthcare provider.
What can fisetin learn from resveratrol?
Resveratrol's trajectory — enormous preclinical promise followed by disappointing human results — is a cautionary parallel. Fisetin may face similar translation challenges, especially given bioavailability limits.
Which is found in red wine?
Resveratrol is found in red grape skin and red wine. Fisetin is found in strawberries, not wine.
Do they activate the same pathways?
Both affect AMPK and NF-κB pathways, but fisetin's primary mechanism is BCL-xL senolytic activity, while resveratrol's primary mechanism is SIRT1 activation.
Which is cheaper?
Both are widely available and similarly priced. Resveratrol has a longer market history.
Are trans- and cis-resveratrol different?
Yes. trans-Resveratrol is the biologically active, stable form used in supplements. cis-Resveratrol is less stable and less studied. Fisetin has no such isomer distinction.
Should I switch from resveratrol to fisetin?
There's no clinical basis to recommend switching. Neither has proven superiority. Fisetin has stronger preclinical senolytic data; resveratrol has more (though inconsistent) human data. Discuss with a healthcare provider.
Key Research Facts
Resveratrol's clinical trajectory — enormous preclinical promise followed by mostly disappointing human trial results — serves as a cautionary parallel for fisetin.
Strong EvidenceBerman et al., NPJ Precision Oncology — doi:10.1038/s41698-017-0038-6
Fisetin showed substantially stronger senolytic activity than resveratrol in the 2018 Mayo Clinic flavonoid screening.
Strong EvidenceYousefzadeh et al., EBioMedicine — doi:10.1016/j.ebiom.2018.09.015
Resveratrol has hundreds of published human clinical trials vs fewer than 15 for fisetin, but many resveratrol trials had methodological limitations.
Strong EvidenceLiterature comparison — PubMed search
Both fisetin and resveratrol have poor oral bioavailability and face similar challenges in translating cell culture findings to clinical efficacy.
Strong EvidenceGrynkiewicz & Demchuk + Berman et al. — Combined reviews
Resveratrol's primary mechanism (SIRT1 activation) differs from fisetin's (BCL-xL senolytic activity), though both affect AMPK and NF-κB pathways.
Strong EvidenceMechanism comparison — Khan et al., 2013 + Berman et al., 2017
The French Paradox hypothesis — that red wine resveratrol explains lower cardiovascular mortality — has been largely debunked.
Strong EvidenceBerman et al., NPJ Precision Oncology — doi:10.1038/s41698-017-0038-6
Neither fisetin nor resveratrol has demonstrated clinically meaningful anti-aging effects in published human clinical trials.
Strong EvidenceEvidence review — Combined literature analysis
Resveratrol has shown modest benefits for glucose metabolism in some trials but inconsistent results for cardiovascular and longevity outcomes.
Moderate EvidenceBerman et al., NPJ Precision Oncology — doi:10.1038/s41698-017-0038-6
No head-to-head comparison trial between fisetin and resveratrol has been registered or published.
Strong EvidenceClinicalTrials.gov — registry search
Species differences in metabolism contribute to the poor translation of both fisetin and resveratrol from animal models to human clinical outcomes.
Strong EvidenceTranslational pharmacology — General principle
Continue Your Research
Explore related topics and take the next step in your cellular health journey.
Related Comparisons
Explore more head-to-head supplement comparisons backed by clinical evidence.
CoQ10 vs PQQ: Which Mitochondrial Supplement Has Better Evidence?
CoQ10 and PQQ are both positioned as mitochondrial supplements, but they work through fundamentally different mechanisms. CoQ10 supports existing mitochondria; PQQ stimulates creation of new ones.
Creatine vs CoQ10: Cellular Energy Supplements Compared
Creatine and CoQ10 both support cellular energy but through entirely different mechanisms. Creatine rapidly regenerates ATP; CoQ10 supports steady-state mitochondrial ATP production.
NMN vs NR: Comparing NAD+ Precursors — Evidence & Differences
NMN and NR are the two leading NAD+ precursors. Both increase cellular NAD+, but differ in metabolic pathways, clinical evidence base, regulatory status, and availability.
Glutathione vs NAC: Direct Supplementation vs Precursor Strategy
Glutathione and NAC represent two strategies for supporting the master antioxidant system: direct supplementation vs. precursor strategy. Each has distinct advantages and evidence.
Curcumin vs Omega-3: Anti-Inflammatory Supplements Compared
Curcumin and omega-3 are the two most popular anti-inflammatory supplements. Omega-3s have strong clinical evidence; curcumin's translation from lab to clinic remains challenging.
Magnesium Forms Compared: Glycinate vs Threonate vs Citrate vs Oxide
Magnesium supplements come in many forms with different bioavailability and clinical applications. Choosing the right form depends on your specific health goals.
Citations & External Resources
ClinicalTrials.gov — Search: Fisetin
PubMed — Fisetin research
EBioMedicine — Yousefzadeh et al. 2018
NPJ Precision Oncology — Berman et al. 2017 (Resveratrol Review)
Frontiers in Chemistry — Grynkiewicz & Demchuk 2019
Related Reading
Fisetin: The Complete Evidence-Based Guide
Fisetin & Longevity: Lifespan Research
How Fisetin Works: Senolytic Mechanisms
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026